CVS Health (CVS) Stock Forecast & Price Target

CVS$89.35-0.44 -0.49%
Medical - Healthcare PlansLarge CapValue Stock
Compare
Market cap$114.32BEnterprise value$176.46BRevenue (TTM)$420.61BMarket positionTop 25%

Score

50
Neutral
Value
73
Quality
32
Growth
46

CVS Health Corp. price target

CVS
Low$103.00
Average$110.59
High$123.00
Upside vs current price+23.8%

The average target of $110.59 is +23.8% versus the current CVS price of $89.35.

CVS Health Corp. analyst ratings

RatingAnalysts
Strong buy7
Buy18
Hold3
Sell0
Strong sell0
ConsensusBuy

28 analysts cover CVS.

CVS Health Corp. EPS and revenue estimates

Published annual figures for CVS on this page are 2026 EPS $8.25, 2027 EPS $8.68. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$8.25$420.89B
2027$8.68$431.45B

Is CVS Health Corp. a buy or sell?

Of the 28 analysts covering CVS Health Corp., 25 rate it a buy (7 strong buy and 18 buy), 3 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The CVS consensus label is Buy, beside 25 buy-side ratings and 0 sell-side ratings.

The average target of $110.59 implies +23.8% versus the current price of $89.35.

The CVS rating block is 28 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the CVS Health Corp. forecast

the CVS Health Corp. is priced by the street between $103.00 and $123.00, average $110.59.

The gap from the $89.35 price to the CVS average is +23.8%.

The CVS rating mix is lopsided rather than split: 25 of 28 analysts are on the buy side, 3 are at hold, and 0 are on the sell side, and the published consensus is Buy.

The recent CVS average ($108.40) is under the quarterly figure ($111.09).

the CVS Health Corp. is followed by 28 analysts, so the range matters more than any one target.

CVS Health Corp. forecast questions

What is the CVS price target?

The published range for CVS is $103.00 to $123.00, with an average of $110.59. That average is +23.8% versus the current price of $89.35.

Is CVS Health Corp. a buy or sell?

Of the 28 analysts covering CVS Health Corp., 25 rate it a buy, 3 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving CVS at 25 buy ratings, 3 holds, and 0 sells.

What is the EPS estimate for CVS Health Corp.?

Analyst EPS estimates for CVS Health Corp.: 2026 $8.25, 2027 $8.68.

What is the revenue estimate for CVS Health Corp.?

Analyst revenue estimates for CVS Health Corp.: 2026 $420.89B, 2027 $431.45B.

How many analysts cover CVS?

28 analysts cover CVS. Their consensus on CVS is Buy, across those 28.

CVS price $89.35 -0.44 -0.49%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener